ResearcherShanghai Jiao Tong UniversityActive in the last 2 years
Yukun Huang
Matched on ORCID iD 0009-0004-8192-7939; OpenAlex author ID A5074174411. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2019: 1 paper · 2020: 2 papers · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper
Papers 5
- High-density lipoprotein-based nanoplatform reprograms tumor microenvironment and enhances chemotherapy against pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.biomaterials.2025.123147↗
- Synthetically Lethal Biomimetic Nutri-hijacker Hitchhikes and Reprograms KRAS Mutation-Driven Metabolic Addictions for Pancreatic Ductal Adenocarcinoma Treatme… Co-author DOI 10.1021/acsnano.3c04069↗
- Sequential delivery of nanoformulated α-mangostin and triptolide overcomes permeation obstacles and improves therapeutic effects in pancreatic cancer. Co-author DOI 10.1016/j.biomaterials.2020.119907↗
- Tailored Chemodynamic Nanomedicine Improves Pancreatic Cancer Treatment via Controllable Damaging Neoplastic Cells and Reprogramming Tumor Microenvironment. First author DOI 10.1021/acs.nanolett.0c02622↗
- Sequential Targeting TGF-β Signaling and KRAS Mutation Increases Therapeutic Efficacy in Pancreatic Cancer. Co-author DOI 10.1002/smll.201900631↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jun Chen · 5 shared papers, 2019–2025 · strength 0.69
- Paper High-density lipoprotein-based nanoplatform reprograms tumor microenvironment and enhances chemotherapy against pancrea… DOI 10.1016/j.biomaterials.2025.123147↗
- Paper Synthetically Lethal Biomimetic Nutri-hijacker Hitchhikes and Reprograms KRAS Mutation-Driven Metabolic Addictions for … DOI 10.1021/acsnano.3c04069↗
- Paper Sequential delivery of nanoformulated α-mangostin and triptolide overcomes permeation obstacles and improves therapeuti… DOI 10.1016/j.biomaterials.2020.119907↗
- Yu Chen · 3 shared papers, 2020–2023 · strength 0.34
- Paper Synthetically Lethal Biomimetic Nutri-hijacker Hitchhikes and Reprograms KRAS Mutation-Driven Metabolic Addictions for … DOI 10.1021/acsnano.3c04069↗
- Paper Sequential delivery of nanoformulated α-mangostin and triptolide overcomes permeation obstacles and improves therapeuti… DOI 10.1016/j.biomaterials.2020.119907↗
- Paper Tailored Chemodynamic Nanomedicine Improves Pancreatic Cancer Treatment via Controllable Damaging Neoplastic Cells and … DOI 10.1021/acs.nanolett.0c02622↗
- Jing Xie · 1 shared paper, 2025 · strength 0.27
- Chen Liang · 2 shared papers, 2019–2020 · strength 0.18
- Paper Sequential delivery of nanoformulated α-mangostin and triptolide overcomes permeation obstacles and improves therapeuti… DOI 10.1016/j.biomaterials.2020.119907↗
- Paper Sequential Targeting TGF-β Signaling and KRAS Mutation Increases Therapeutic Efficacy in Pancreatic Cancer. DOI 10.1002/smll.201900631↗
- Jingxian Feng · 2 shared papers, 2019–2020 · strength 0.18
- Paper Sequential delivery of nanoformulated α-mangostin and triptolide overcomes permeation obstacles and improves therapeuti… DOI 10.1016/j.biomaterials.2020.119907↗
- Paper Sequential Targeting TGF-β Signaling and KRAS Mutation Increases Therapeutic Efficacy in Pancreatic Cancer. DOI 10.1002/smll.201900631↗
- Qian Zhang · 1 shared paper, 2019 · strength 0.08
- Yuanyuan Pei · 1 shared paper, 2019 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.